BRPI0814217A2 - Meio de cultura para haemophulus influenzae de tipo b - Google Patents

Meio de cultura para haemophulus influenzae de tipo b

Info

Publication number
BRPI0814217A2
BRPI0814217A2 BRPI0814217-3A2A BRPI0814217A BRPI0814217A2 BR PI0814217 A2 BRPI0814217 A2 BR PI0814217A2 BR PI0814217 A BRPI0814217 A BR PI0814217A BR PI0814217 A2 BRPI0814217 A2 BR PI0814217A2
Authority
BR
Brazil
Prior art keywords
haemophulus
culture media
influenzae type
influenzae
type
Prior art date
Application number
BRPI0814217-3A2A
Other languages
English (en)
Inventor
Ghislaine Maitre-Wilmotte
Bachra Rokbi
Denis Speck
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39027590&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0814217(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Publication of BRPI0814217A2 publication Critical patent/BRPI0814217A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/18—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/92—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/21—Haemophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0814217-3A2A 2007-07-10 2008-07-01 Meio de cultura para haemophulus influenzae de tipo b BRPI0814217A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0756371A FR2918671B1 (fr) 2007-07-10 2007-07-10 Milieu de culture d'haemophilus influenzae type b.
PCT/FR2008/051223 WO2009007641A2 (fr) 2007-07-10 2008-07-01 Milieu de culture pour haemophilus influenzae de type b

Publications (1)

Publication Number Publication Date
BRPI0814217A2 true BRPI0814217A2 (pt) 2014-10-21

Family

ID=39027590

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814217-3A2A BRPI0814217A2 (pt) 2007-07-10 2008-07-01 Meio de cultura para haemophulus influenzae de tipo b

Country Status (14)

Country Link
US (1) US8673617B2 (pt)
EP (1) EP2167639B1 (pt)
JP (1) JP5611822B2 (pt)
KR (1) KR101545641B1 (pt)
CN (1) CN101688174B (pt)
AR (1) AR067131A1 (pt)
AU (1) AU2008273968B2 (pt)
BR (1) BRPI0814217A2 (pt)
CA (1) CA2693101A1 (pt)
FR (1) FR2918671B1 (pt)
IL (1) IL202495A (pt)
MX (1) MX2009013634A (pt)
WO (1) WO2009007641A2 (pt)
ZA (1) ZA200908450B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2405759B1 (en) 2009-03-11 2018-12-26 Monsanto Technology LLC Herbicidal formulations comprising glyphosate and alkoxylated glycerides
PT105484A (pt) 2011-01-14 2012-07-16 Univ Nova De Lisboa Um método de ambientómica funcional para engenharia de meio de cultura celular
FR2992656B1 (fr) * 2012-07-02 2016-10-07 Sanofi Pasteur Procede de production d'antigenes haemophilus influenzae type b
CN104487086B (zh) * 2012-07-07 2019-08-30 巴拉特生物技术国际有限公司 无动物源的不含酒精的疫苗组合物及其制备方法
WO2014200656A1 (en) 2013-06-13 2014-12-18 Danisco Us Inc. Alpha-amylase from streptomyces umbrinus
WO2014200657A1 (en) 2013-06-13 2014-12-18 Danisco Us Inc. Alpha-amylase from streptomyces xiamenensis
WO2014200658A1 (en) 2013-06-13 2014-12-18 Danisco Us Inc. Alpha-amylase from promicromonospora vindobonensis
EP3011020A1 (en) 2013-06-17 2016-04-27 Danisco US Inc. Alpha-amylase from bacillaceae family member
WO2015050724A1 (en) 2013-10-03 2015-04-09 Danisco Us Inc. Alpha-amylases from a subset of exiguobacterium, and methods of use, thereof
US20160160199A1 (en) 2013-10-03 2016-06-09 Danisco Us Inc. Alpha-amylases from exiguobacterium, and methods of use, thereof
MX2016006489A (es) 2013-11-20 2016-08-03 Danisco Us Inc Alfa-amilasas variantes que tienen susceptibilidad reducida a la escision por proteasas y metodos de uso.
KR101723167B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101729251B1 (ko) * 2015-04-28 2017-04-21 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR101723168B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
CN105199998B (zh) * 2015-11-04 2016-06-29 长春长生生物科技有限责任公司 Hib综合培养基、b型流感嗜血杆菌结合疫苗及其制备方法
WO2017173190A2 (en) 2016-04-01 2017-10-05 Danisco Us Inc. Alpha-amylases, compositions & methods
WO2017173324A2 (en) 2016-04-01 2017-10-05 Danisco Us Inc. Alpha-amylases, compositions & methods
PL244159B1 (pl) 2018-12-17 2023-12-11 Univ Gdanski Odczynnik do ochrony bakterii podczas liofilizacji i zastosowanie odczynnika do ochrony bakteryjnych szczepów probiotycznych podczas liofilizacji
WO2021108502A1 (en) * 2019-11-27 2021-06-03 Evelo Biosciences, Inc. Methods and compositions for culturing hemoglobin-dependent bacteria
CN110747148A (zh) * 2019-12-02 2020-02-04 天津瑞普生物技术股份有限公司 一种副鸡禽杆菌培养基的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
AU653964B2 (en) 1990-12-06 1994-10-20 Becton Dickinson & Company Fastidious organism supplement
FI940700A7 (fi) 1991-08-16 1994-02-15 Merck & Co Inc Prosessi lipidiä sisältävän bakteerisen kapsulaarisen polysakkaridin k onvertoimiseksi lipidivapaaksi polysakkaridiksi
US5371197A (en) 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
PL184872B1 (pl) * 1995-06-23 2003-01-31 Smithkline Beecham Biolog Kombinowana szczepionkaĆ zestaw do przygotowania kombinowanej szczepionkiĆ sposób wytwarzania kombinowanej szczepionki i jej zastosowanie
DE69838383T2 (de) 1997-05-28 2008-06-05 Novartis Vaccines And Diagnostics S.R.L. Kulturmedium mit sojabohnenextrakt als aminosäuren-quelle und ohne proteinkomplexe tierischen ursprungs
US20040087020A1 (en) 1997-05-28 2004-05-06 Chiron S.P.A. Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
FR2782093B1 (fr) 1998-07-24 2002-02-08 Agronomique Inst Nat Rech Procede de preparation de cultures de bacteries lactiques
CN1709505B (zh) * 2005-07-13 2010-06-16 北京绿竹生物制药有限公司 多价细菌荚膜多糖-蛋白质结合物联合疫苗

Also Published As

Publication number Publication date
KR20100049546A (ko) 2010-05-12
JP2010532985A (ja) 2010-10-21
CN101688174A (zh) 2010-03-31
AR067131A1 (es) 2009-09-30
WO2009007641A3 (fr) 2009-02-26
IL202495A (en) 2014-01-30
US20090017074A1 (en) 2009-01-15
JP5611822B2 (ja) 2014-10-22
MX2009013634A (es) 2010-01-26
WO2009007641A8 (fr) 2009-11-05
CN101688174B (zh) 2015-07-29
US8673617B2 (en) 2014-03-18
CA2693101A1 (en) 2009-01-15
ZA200908450B (en) 2011-02-23
EP2167639B1 (fr) 2016-08-17
AU2008273968B2 (en) 2014-04-24
IL202495A0 (en) 2011-08-01
WO2009007641A2 (fr) 2009-01-15
KR101545641B1 (ko) 2015-08-21
EP2167639A2 (fr) 2010-03-31
FR2918671B1 (fr) 2010-10-15
AU2008273968A1 (en) 2009-01-15
FR2918671A1 (fr) 2009-01-16

Similar Documents

Publication Publication Date Title
BRPI0814217A2 (pt) Meio de cultura para haemophulus influenzae de tipo b
DK2522717T3 (da) Oligopeptid-frie cellekulturmedier
BRPI0812493A2 (pt) Meio de fechamento
CR10781A (es) Medios disenado racionalmente para cultivo celular
BRPI0919632A2 (pt) meio filtrante multifases
BRPI0911096A2 (pt) meio de filtração dissipador de estática
DK2006009T3 (da) Filtermedium
DE602008005237D1 (de) Tintenstrahlaufzeichnungsverfahren
PL2634242T3 (pl) Ulepszony sposób hodowli komórek
BR112013017632A2 (pt) meio de cultura celular
GB0613756D0 (en) Cell culture medium
DK3375867T3 (da) Feeder-frit kultursystem
EP2211787A4 (en) MITRAL SPACEUR
EP2183917A4 (en) MEDIA BASED RECOMMENDATIONS
DE602008001816D1 (de) Verbundstofffiltermedien
BRPI0909866A2 (pt) Meio condicionado de células progenitoras de fígado.
BR112013014759A2 (pt) meio de gravação com jato de tinta
DE602007008627D1 (de) Zellkulturmedium
BRPI0916060A2 (pt) "interconector para fluidos"
GB2435475B (en) Selective culture medium
DE112009002315A5 (de) Flüssigkristallines Medium
BRPI0816973A2 (pt) Meio e método de acabamento
DE112007000676A5 (de) Flüssigkristallines Medium
BRPI0810088A2 (pt) Regime de vacinação para vacinas de células b
GB0610009D0 (en) Culture medium

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B350 Update of information on the portal [chapter 15.35 patent gazette]